Cidara Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Cidara Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2014 to Q3 2024.
  • Cidara Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $751K, a 5.65% decline year-over-year.
  • Cidara Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $3.08M, a 6.03% increase year-over-year.
  • Cidara Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.06M, a 17.4% decline from 2022.
  • Cidara Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.71M, a 7.7% decline from 2021.
  • Cidara Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.01M, a 1.86% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $3.08M $751K -$45K -5.65% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $3.12M $703K -$92K -11.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $3.22M $795K +$155K +24.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $3.06M $830K +$157K +23.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-22
Q3 2023 $2.9M $796K -$46K -5.46% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $2.95M $795K -$57K -6.69% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $3.01M $640K -$698K -52.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $3.71M $673K -$690K -50.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-22
Q3 2022 $4.4M $842K -$59K -6.55% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $4.45M $852K -$19K -2.18% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $4.47M $1.34M +$459K +52.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $4.01M $1.36M +$516K +60.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 $3.5M $901K -$101K -10.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $3.6M $871K -$124K -12.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $3.72M $879K -$367K -29.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $4.09M $847K -$176K -17.2% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-23
Q3 2020 $4.27M $1M -$507K -33.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $4.77M $995K -$262K -20.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $5.04M $1.25M -$38K -2.96% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $5.07M $1.02M -$341K -25% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-07
Q3 2019 $5.41M $1.51M +$224K +17.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $5.19M $1.26M -$343K -21.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $5.53M $1.28M -$177K -12.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $5.71M $1.36M -$143K -9.49% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $5.85M $1.29M -$270K -17.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $6.12M $1.6M -$1K -0.06% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $6.12M $1.46M +$410K +39% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $5.71M $1.51M +$415K +38% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 $5.3M $1.56M +$245K +18.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $5.05M $1.6M +$492K +44.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $4.56M $1.05M +$218K +26.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $4.34M $1.09M +$304K +38.6% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-27
Q3 2016 $4.04M $1.31M +$544K +71% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $3.5M $1.11M +$269K +32% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $3.23M $833K +$194K +30.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $3.03M $788K +$613K +350% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 $2.42M $766K +$717K +1463% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $1.7M $840K +$834K +13900% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 $869K $639K +$637K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 $232K $175K Oct 1, 2014 Dec 31, 2014 10-K 2016-03-18
Q3 2014 $49K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 $6K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 $2K* Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.